This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Harvard Bioscience Inc (HBIO)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 14.13M 25.77M 20.68M 17.92M
Receivables 20.88M 17.66M 18.98M 17.58M
Inventories 20.53M 15.78M 17.76M 18.16M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 57.06M 60.75M 58.97M 57.56M
Property, Plant & Equipment, Gross 20.20M 18.82M 17.86M 13.38M
Accumulated Depreciation & Depletion 15.01M 14.44M 13.31M 10.30M
Property, Plant & Equipment, Net 5.19M 4.38M 4.55M 3.09M
Intangibles 22.40M 20.30M 22.50M 23.64M
Other Non-Current Assets 380.00K 316.00K 490.00K 215.00K
Total Non-Current Assets 78.85M 74.71M 74.51M 69.07M
Liabilities & Shareholder Equity
Total Assets 135.92M 135.46M 133.48M 126.63M
Accounts Payable 6.29M 4.68M 4.68M 4.96M
Short Term Debt 5.00M 5.00M 0.00 0.00
Other Current Liabilities 1.58M 685.00K 1.23M 794.00K
Total Current Liabilities 18.10M 16.08M 9.90M 9.56M
Long Term Debt 16.45M 19.75M 12.95M 16.30M
Deferred Income Taxes 1.32M 160.00K 277.00K 369.00K
Other Non-Current Liabilities 4.57M 4.98M 6.14M 4.91M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 22.35M 24.89M 19.37M 21.58M
Total Liabilities 40.45M 40.98M 29.27M 31.14M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 95.47M 94.48M 104.21M 95.50M
Common Par 397.00K 390.00K 370.00K 362.00K
Additional Paid In Capital 206.66M 202.45M 196.63M 191.16M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -92.68M -95.04M -77.26M -79.63M
Treasury Stock -10.67M -10.67M -10.67M -10.67M
Other Equity Adjustments -8.23M -2.64M -4.86M -5.72M
Total Capitalization 111.92M 114.24M 117.16M 111.80M
Total Equity 95.47M 94.48M 104.21M 95.50M
Total Liabilities & Stock Equity 135.92M 135.46M 133.48M 126.63M
Total Common Shares Outstanding 32.56M 31.64M 29.38M 28.54M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 7.75M 7.75M 7.75M 7.75M
Basic Weighted Shares Outstanding 32.17M 30.38M 28.80M 28.45M
Diluted Weighted Shares Outstanding 33.24M 31.91M 29.42M 29.82M
Number of Employees 417 345 398 375
Number of Part-Time Employees 30 23 24 21

HBIO Harvard Bioscience Inc

Chart of HBIO

Analysts Ratings for HBIO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

HBIO Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs